Extra Efforts Needed To Boost Belgian Biosimilars

At the halfway point of a pilot scheme to encourage the uptake of anti-TNF biosimilars in Belgium, local off-patent industry association Medaxes has welcomed the gradual progress made but insists that there is much more to be done.

Belgium
Belgium’s Medaxes Is Flying The Flag For Biosimilars • Source: Shutterstock

Mid-year results from a Belgian 2019 pilot project designed to encourage the uptake of anti-TNF biosimilars adalimumab and etanercept outside of the hospital setting show that prescribing rates are moving in the right direction but still need a substantial lift to achieve the full potential of biosimilars, according to local off-patent industry association Medaxes.

Acknowledging that the incentives offered by the project were provided due to the fact that “the use of biosimilars in...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.